Loading...

Table of Content

    15 October 2020 Volume 38 Issue 10
      
    Effect of exchange transfusion in the treatment of pertussis in children with hyperleukocytemia
    GAN Chuan, WU Xiaoying, XU Hongmei, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  721.  doi:10.3969/j.issn.1000-3606.2020.10.001
    Abstract ( 783 )   PDF (1318KB) ( 253 )  
    Related Articles | Metrics
    Objective To explore the effect and timing of exchange transfusion on the treatment of pertussis in hyperleukocytemia. Method? The?effects?of?exchange?transfusion?and?other?treatments?in?pertussis?children?with?the?highest? white?blood?cell?count?(WBC)?of?>50×109/L?were?retrospectively?analyzed.?Results? A?total?of?72?children?with?pertussis?(24? boys?and?48?girls),?with?the?highest?WBC?of?>50×109/L?were?studied.?They?were?divided?into?the?exchange?transfusion?group?(17? cases)?and?the?non-exchange?transfusion?group?(55?cases).?Compared?with?the?non-exchange?transfusion?group,?the?interval?from? onset?to?admission?was?shorter,?the?incidence?of?severe?pneumonia?and?heart?failure?was?higher,?and?the?highest?WBC?was?higher? in?the?exchange?transfusion?group?(P<0.05).?The?distribution?of?the?highest?WBC?was?statistically?significant?different?between? the?two?groups?(P<0.01),?and?the?proportion?of?the?highest?WBC?≥70×109/L?in?the?exchange?transfusion?group?was?higher.?The? decrease?rate?of?WBC?in?children?with?the?highest?WBC?≥70×109/L?in?the?exchange?transfusion?group?was?higher?than?that?in?the? non-exchange?transfusion?group,?and?the?difference?was?statistically?significant?(P<0.05).?When?the?ROC?curve?of?the?highest? WBC?was?plotted?to?predict?pertussis?death?in?the?non-exchange?transfusion?group,?it?was?found?that,?at?the?optimal?critical?value? of?WBC?71.9×109/L,?the?sensitivity?and?specificity?of?the?prediction?of?death?were?80%?and?90%,?and??AUC?was?0.89?(95%?CI: 0.74~1.00,?P=0.004).?Conclusions? Exchange?transfusion?is?an?effective?treatment?to?reduce?WBC,?but?its?effect?on?improving? clinical?symptoms?is?not?clear.?When?WBC?is?(50~71.9)×109/L,?other?indicators?need?to?be?considered?for?whether?exchange? transfusion?should?be?applied.?When?WBC?≥71.9×109/L,?transfusion?therapy?may?be?required.?
    The level of antibodies to Bordetella pertussis among pregnant women and their newborns in Jinan area
    LIU Yanqin, WANG Li, YU Huafeng, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  726.  doi:10.3969/j.issn.1000-3606.2020.10.002
    Abstract ( 329 )   PDF (1245KB) ( 203 )  
    Related Articles | Metrics
    Objective? To?explore?the?pertussis?antibody?levels?of?mothers?of?different?ages?and?their?newborns.? Methods Enzyme-linked?immunosorbent?assay?was?used?to?detect?the?pertussis?antibody?levels?in?the?peripheral?blood?of?100? pairs?of?healthy?mothers?of?different?ages?and?the?umbilical?cord?blood?(newborn?side)?of?their?newborns.?Results The median levels?of?pertussis?IgG?antibodies?in?women?born?in?the?1970s,?1980s?and?1990s?were?7.99?IU/mL,?5.00?IU/mL?and?5.71?IU/ mL,?respectively,?and?the?difference?among?the?three?groups?were?statistically?significant?(P<0.05).?Serum?pertussis?IgG?antibody? was?negative?in?97%?of?the?mothers?and?negative?in?92%?of?the?newborns.?There?was?a?positive?correlation?between?maternal? serum?pertussis?IgG?antibody?levels?and?neonatal?umbilical?cord?blood?pertussis?IgG?antibody?levels?(r=0.76, P<0.001).? Conclusion? Current?maternal?pertussis?antibodies?cannot?protect?women?from?pertussis?infection,?and?the?protective?effect?of?fetal? antibodies?obtained?from?the?mother?is?weak.?Further?adjustment?of?immunization?strategies?to?prevent?pertussis?may?be?considered.?
    Clinical analysis of pulmonary abscess in 94 children
    TAN Jing, LI Zhuxia, LEI Yinlan, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  730.  doi:10.3969/j.issn.1000-3606.2020.10.003
    Abstract ( 447 )   PDF (1269KB) ( 230 )  
    Related Articles | Metrics
    Objective? To?explore?the?diagnosis?and?treatment?of?pulmonary?abscess?in?children.?Method The clinical data?of?pulmonary?abscess?in?94?children?were?retrospectively?analyzed.?Results? There?were?totally?94?children?(57?boys?and? 37?girls)?with?a?median?age?of?2.3?years?(1?month?to?17?years?and?5?months),?including?54?children?with?primary?pulmonary? abscess?and?40?children?with?secondary?pulmonary?abscess.?The?common?symptoms?were?fever,?cough,?shortness?of?breath,? dyspnea?and?chest?pain.?Compared?with?primary?pulmonary?abscess?group,?the?proportion?of?albumin?<30?g/L?and?the?level?of? CRP?were?higher?in?the?secondary?lung?abscess?group?(P<0.05).?Sixty-six?children?were?detected?positive?for?pathogens,?and?81? strains?were?detected.?Streptococcus pneumoniae and Mycoplasma pneumoniae?were?the?main?pathogens?in?primary?pulmonary? abscess?group,?while?Staphylococcus aureus,?Streptococcus pneumoniae and Klebsiella pneumoniae?were?the?main?pathogens?in? secondary?pulmonary?abscess?group.?All?94?patients?were?treated?with?antibiotics,?2?with?antifungal?therapy?and?18?with?surgery.? Ninety-one?children?were?discharged?after?remission.?Three?patients?had?poor?outcomes?(2?gave?up?treatment?and?1?died)?and?all? of?them?were?secondary?pulmonary?abscesses.?Compared?with?the?primary?pulmonary?abscess?group,?the?secondary?pulmonary? abscess?group?had?a?higher?proportion?of?ICU?cases?and?longer?hospital?stay,?and?the?differences?were?statistically?significant? (P<0.05).?Conclusion? Children?with?primary?and?secondary?pulmonary?abscesses?are?commonly?infected?with?Streptococcus pneumoniae and Staphylococcus aureus,?respectively,?and?the?antibiotic?treatment?is?required,?and?surgery?is?required?in?some? cases.?Secondary?pulmonary?abscess?has?more?severe?symptoms?and?longer?treatment?time?than?primary?pulmonary?abscess.
    Effect of heparin combined with warfarin in the treatment of thrombogenesis in children
    DU Qingxia, LI Lei, BIE Wenhui, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  736.  doi:10.3969/j.issn.1000-3606.2020.10.004
    Abstract ( 586 )   PDF (1300KB) ( 312 )  
    Related Articles | Metrics
    Objective? To?explore?the?common?causes?of?thrombogenesis?in?children?and?observe?the?anticoagulant? effect?of?heparin?combined?with?warfarin.?Methods? The?clinical?data?of?children?diagnosed?with?thrombosis?and?receiving? anticoagulant?treatment?of?heparin?combined?with?warfarin?from?March?2017?to?March?2019?were?analyzed?retrospectively.? According?to?the?target?value?of?international?standardized?ratio?(INR)?during?treatment,?the?children?were?divided?into?INR? 1.0~1.5?group,?INR?1.5~2.0?group?and?INR>2.0?group,?and?the?duration?and?efficacy?of?anticoagulation?therapy?among?the?three? groups?were?compared?and?analyzed.?Results? Sixty-four?children?were?included?(40?males?and?24?females),?and?29?patients? (45.3%)?were?younger?than?2?years?old.?The?primary?diseases?were?mainly?hematological?tumor?diseases?(36?cases,?56.2%)?and? cardiovascular?diseases?(20?cases,?31.2%).?Thrombogenesis?was?caused?by?central?venous?catheterization?in?38?cases?(59.38%),? peripheral?arteriovenous?puncture?in?12?cases?(18.75%),?severe?infection?in?4?cases?(6.25%),?tumor?in?4?cases?(6.25%),?femoral? venous?catheterization?in?2?cases?(3.12%),?arrhythmia?in?2?cases?(3.12%),?and?coronary?artery?disease?of?Kawasaki?disease?in?2? cases?(3.12%).?There?were?20?cases?in?the?INR?1.0~1.5?group?(11?males?and?9?females),?28?cases?in?the?INR?1.5~2.0?group?(18? males?and?10?females),?and?13?cases?in?the?INR>2.0?group?(9?males?and?4?females).?There?was?a?statistically?significant?difference? in?the?median?time?of?anticoagulation?treatment?among?the?three?groups?(P<0.05).?In?pairwise?comparison,?the?anticoagulation? treatment?time?in?the?INR?1.5~2.0?group?was?significantly?shorter?than?that?in?the?INR?1.0~1.5?group,?and?the?difference?was? statistically?significant?(P=0.014).?Conclusion? Anticoagulation?is?the?main?method?for?the?treatment?of?thrombogenesis?in? children?and?its?efficacy?is?good.?Low-dose?warfarin?anticoagulation?can?inhibit?thrombogenesis?and?there?is?no?need?to?adjust? INR?to?>2.0.
    A retrospective cohort study on gene variation and clinical features of steroid resistant nephrotic syndrome in children
    CAI Xiaoyi, DENG Huiying, CHEN Ye, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  740.  doi:10.3969/j.issn.1000-3606.2020.10.005
    Abstract ( 389 )   PDF (1255KB) ( 482 )  
    Related Articles | Metrics
    Objective? To?explore?the?gene?variation?and?clinical?characteristics?of?steroid?resistant?nephrotic?syndrome? (SRNS).?Methods? The?clinical?data?of?58?children?with?SRNS?diagnosed?by?whole?exon?sequencing?(WES)?from?May? 2015?to?June?2019?were?retrospectively?analyzed,?and?the?clinical?indicators,?renal?pathological?types,?remission?rate?of? immunosuppressive?therapy?and?renal?survival?time?were?compared?between?children?with?or?without?gene?mutation.?Results? In? 58?children?with?SRNS?(35?boys?and?23?girls),?the?age?at?onset?ranged?from?1?month?to?12?years.?Gene?variation?was?detected? in?31?cases,?mainly?WT1?and?NPHS1.?The?incidence?of?renal?insufficiency?in?31?cases?with?gene?mutation?was?significantly? higher?than?that?in?27?cases?without?gene?mutation?(P<0.05).?The?complete?remission?rate?of?children?without?gene?mutation?was? 73.08%,?which?was?significantly?higher?than?that?of?children?with?gene?mutation?(41.18%),?and?the?difference?was?statistically? significant?(P<0.05).?The?kidney?survival?time?of?children?with?genetic?mutation?was?(39.40±6.95)?months,?as?compared? with?(58.90±4.87)?months?in?children?without?genetic?mutation?was,?and?the?difference?was?statistically?significant?(χ2=9.98,? P<0.01).?Conclusion? Gene?detection?is?of?great?significance?in?etiological?diagnosis,?treatment,?prognosis?and?recurrence? prediction?after?renal?transplantation?in?children?with?SRNS.
    Comparative analysis of clinical characteristics between Kawasaki disease and systemic macrophage activation syndrome and systematic-onset juvenile idiopathic arthritis
    ZHOU Weiran, LIU Xuemei, DONG Linlin, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  744.  doi:10.3969/j.issn.1000-3606.2020.10.006
    Abstract ( 742 )   PDF (1232KB) ( 474 )  
    Related Articles | Metrics
    Objective? To?explore?the?comparison?of?the?clinical?features?between?Kawasaki?disease?(KD)?and?systematiconset?juvenile?idiopathic?arthritis?(SJIA)?with?macrophage?activation?syndrome?(MAS).?Method The clinical data of 5 cases of KD-MAS?and?8?cases?of?SJIA-MAS?children?admitted?from?September?2015?to?September?2019?were?retrospectively?analyzed.? Results? The?children?with?KD-MAS?were?all?male,?aged?from?5?months?to?7?years?and?10?months.?In?the?SJIA-MAS?group,?8? children?(3?boys?and?5?girls)?aged?from?1?year?and?2?months?to?11?years?had?10?times?of?MAS?in?total,?among?whom,?one?boy? and?one?girl?had?two?times?of?MAS?respectively,?and?the?age?at?recurrence?was?6?years?and?7?months,?and?8?years?and?5?months,? respectively.?The?main?clinical?manifestations?of?all?the?children?were?persistent?high?fever.?Comparison?of?laboratory?indicators? showed?that?ferritin?level?was?correlated?with?LDH?level?(r=0.071,?P=0.03).?The?median?ferritin?was?14900?ng/mL?and?the? median?LDH?was?1264.5?U/L?in?the?SJIA-MAS?group.?The?median?ferritin?and?LDH?in?the?KD-MAS?group?was?736?ng/ml?and? 492?U/L?respectively,?and?the?differences?between?the?two?groups?were?statistically?significant?(both?P<0.05).?One?case?in?the? KD-MAS?group?and?3?cases?in?the?SJIA-MAS?group?underwent?genetic?testing,?and?no?HLH-related?genes?were?detected.?The? condition?of?all?children?were?able?to?be?effectively?controlled.?Conclusion? LDH?may?serve?as?another?sensitive?indicator?for? early?identification?of?MAS?in?addition?to?ferritin.?There?are?differences?between?KD-MAS?and?SJIA-MAS?in?ferritin?and?LDH? levels.?The?application?of?SJIA-MAS?2016?diagnostic?criteria?to?diagnose?KD-MAS?is?more?sensitive.?KD-MAS?can?achieve? better?curative?effect?through?glucocorticoid?treatment,?and?the?prognosis?is?better?than?SJIA-MAS.
    Clinical analysis of metabolic bone disease in 6 premature infants with fracture
    LIU Yingli, ZHOU Lin, ZHANG Yonghong, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  749.  doi:10.3969/j.issn.1000-3606.2020.10.007
    Abstract ( 451 )   PDF (1330KB) ( 253 )  
    Related Articles | Metrics
    Objective? To?explore?the?clinical?features?of?metabolic?bone?disease?with?fracture?in?preterm?infants.? Method? The?clinical?data?of?metabolic?bone?disease?with?fractures?in?6?neonates?admitted?from?January?2016?to?April?2020?were? retrospectively?analyzed.?Results? Among?the?6?newborns?(5?boys?and?one?girl),?the?median?gestational?age?was?27.1?weeks,? and?the?median?birth?weight?was?900?g.?Among?the?6?newborns,?multiple?costal?fractures?occurred?in?one?case,?left?humeral? fracture?occurred?in?one?case,?left?femoral?fracture?occurred?in?two?cases,?femoral?and?humeral?fracture?occurred?in?two?cases,? and?right?humeral?fracture?occurred?in?one?case.?The?blood?phosphorus?of?the?6?newborns?were?all?<1.8?mmol/L,?and?the?blood? alkaline?phosphatase?were?all?>600?IU/L,?and?the?blood?calcium?were?in?the?normal?range.?All?the?6?neonates?were?complicated? with?retinopathy?of?prematurity?and?bronchopulmonary?dysplasia,?and?one?was?complicated?with?necrotizing?enterocolitis.?After? active?treatment?with?calcium,?phosphorus?and?vitamin?D3,?6?neonates?were?discharged?from?hospital?after?recovery?from?fracture.? Conclusion? Premature?infants?with?very?low?birth?weight?should?pay?attention?to?avoid?metabolic?osteopathy?complicated?with? fracture.
    Incomplete Kawasaki disease with initial symptoms of fever and jaundice: a report of 2 cases and literature review
    MA Yingying, PENG Shao, CHU Weihong, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  754.  doi:10.3969/j.issn.1000-3606.2020.10.008
    Abstract ( 553 )   PDF (1236KB) ( 277 )  
    Related Articles | Metrics
    Objective To?explore?the?clinical?features?of?incomplete?Kawasaki?disease?(IKD)?with?first?symptoms?of? fever?and?jaundice.?Method The?clinical?data?of?incomplete?KD?with?the?first?symptoms?of?fever?and?jaundice?in?2?cases?were? retrospectively?analyzed,?and?relevant?literature?was?reviewed.?Results In?two?patients?(3-year-?and?9-month-old?boy?and?a? 10-year-old?girl),?the?main?early?symptoms?were?fever,?yellowish?skin,?lymphadenopathy?and?bulbar?conjunctival?hyperemia,? and?no?rash.?They?presented?with?periungual?and?perianal?desquamation?and?coronary?artery?ectasia?at?the?later?stage.?The?boy? developed?oculomotor?palsy?and?gamma?globulin?resistance,?and?the?girl?developed?KD?shock?syndrome.?Conclusion The diagnosis?in?IKD?children?with?fever?and?jaundice?as?the?first?symptoms?may?be?delayed?due?to?atypical?symptoms.
    Antimicrobial resistance and resistance genes analysis of extended-spectrum β-lactamase producing Klebsiella pneumoniae in children with severe infection
    QIU Haiyan, WU Junhua
    Journal of Clinical Pediatrics. 2020, 38(10):  757.  doi:10.3969/j.issn.1000-3606.2020.10.009
    Abstract ( 408 )   PDF (1262KB) ( 297 )  
    Related Articles | Metrics
     Objective? To?understand?the?distribution?of?drug?resistance?and?genotype?of?extended-spectrum?β-lactamase? (ESBL)-producing?Klebsiella pneumoniae?(KP)?in?children?with?severe?infection.?Methods? KP?routinely?separated?in?intensive? care?unit?was?collected,?and?ESBLs?detection?was?conducted?by?double-paper?cooperative?test.?Drug?sensitivity?detection?was? conducted?by?microbroth?dilution?method,?and?drug?resistance?genes?including?intl1,?acc,?ampC,?CTX-M1,?CTX-M3,?DHA1,? OXA,?shv,?tem,?NDM,?DHA1,??fox and per?were?detected?by?polymerase?chain?reaction?(PCR).?Results? A?total?of?143?KP?strains? were?isolated?mainly?from?respiratory?specimens?(81.8%),?73.4%?of?which?were?sputum?specimens.?The?78?strains?of?ESBLs? KP?showed?varying?degrees?of?resistance?to?24?antibiotics,?and?the?rates?of?resistance?to?ampicillin,?cefazolin?and?piperacillin?were? up?to?100%.?The?rate?of?resistance?to?aztreonam,?ceftriaxone?and?tetracycline?were?over?74%.?The?rates?of?sensitivity?to?amikacin,? donipenem,?ertapenem,?meropenem,?tigecycline?and?nitrofurantoin?were?all?100%,?and?one?KP?strain?resistant?to?imipenem?was? detected.?The?drug?resistance?gene?test?showed?that?DHA1,?Shv,?Tem,?CTX-M1,?CTX-M3 and Intl1?were?all?detected?to?varying? degrees,?and?the?detection?rate?of?Shv?was?as?high?as?87.2%.?Strains?with?2,?3?and?≥4??resistant?genes?accounted?for?30.7%,? 62.8%?and?24.4%,?respectively.?Conclusion? The?rate?of?ESBLs?producing?KP?in?severe?infection?children?is?high?and?the? pattern of multidrug resistance is complex.
    Application of splenectomy in Wiskott-Aldrich syndrome with eczema and thrombocytopenia in children
    DAI Rongxin, LI Wenyan, DU Xiao, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  760.  doi:10.3969/j.issn.1000-3606.2020.10.010
    Abstract ( 456 )   PDF (1342KB) ( 430 )  
    Related Articles | Metrics
    Objectives To?explore?the?effect?of?splenectomy?on?the?prognosis?of?Wiskott-Aldrich?syndrome?(WAS)?with? eczema?and?thrombocytopenia.?Method The?clinical?data?of?mild?WAS?syndrome?in?a?child?who?underwent?splenectomy?in?2015? were?retrospectively?analyzed,?and?the?relevant?literature?was?reviewed.?Results A?boy?had?multiple?episodes?of?skin?and?mucous? membrane?bleeding?and?gastrointestinal?bleeding?after?birth,?and?the?lowest?platelet?count?was?3×109/L.?X-linked?thrombocytopenia? (XLT)?was?diagnosed?by?genetic?testing?at?the?age?of?12?years.?Splenectomy?was?performed?at?the?age?of?16?years?due?to?the? recurrence?of?skin?and?mucosal?bleeding.?No?targeted?vaccinations?were?given?before?and?after?the?operation.?On?the?2nd?day? after?splenectomy,?the?platelet?count?rose?to?normal.?On?the?26th?day?after?operation,?the?patient?developed?fever,?skin?and?mucous? membrane?hemorrhage,?accompanied?by?severe?thrombocytopenia,?so?he?was?diagnosed?with?severe?sepsis.?After?anti-infection?and? supportive?treatment?for?nearly?3?months,?the?temperature?was?gradually?stabilized,?respiratory?symptoms?was?improved,?and?platelet? count?was?stabilized?to?a?normal?level.?It?had?been?reported?that?platelet?counts?in?WAS?and?XLT?children?undergoing?splenectomy? could?rise?to?normal?levels,?but?these?children?were?at?risk?of?severe?postoperative?infection.?Conclusion Splenectomy is one of the?alternative?treatment?options?for?XLT?patients?with?refractory?thrombocytopenia?and?with?difficulty?in?conventional?treatment.? Prophylactic?vaccination?and?prophylactic?use?of?antibiotics?are?necessary?before?surgery.?
    Clinical and gene mutation analysis of paroxysmal exercise-induced dyskinesia in one family
    HU Shuxiang, LI Pei, WANG Yangdan, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  765.  doi:10.3969/j.issn.1000-3606.2020.10.011
    Abstract ( 414 )   PDF (1416KB) ( 188 )  
    Related Articles | Metrics
    Objective? To explore the clinical manifestations and SLC2A1 gene mutation in paroxysmal exercise-induced dyskinesia?(PED).?Methods? The?clinical?data?of?the?proband?and?his?families?were?collected.?The?genomic?DNA?of?the?proband? was?sequenced?by?high-throughput?sequencing.?The?specific?coding?region?on?SLC2A1 ?gene?of?the?proband?and?his?families?were? amplified?by?polymerase?chain?reaction?and?verified?by?the?first-generation?sequencing.?Results? The?proband?was?an?11-yearold?male?who?developed?dyskinesia?after?exercising?at?the?age?of?8.?Gene?sequencing?showed?that?the?proband?had?heterozygous? variation?of?c.?940G>A?(p.?Gly314Ser)?in?exon?7?of?SLC2A1?gene.?It?was?confirmed?as?the?pathogenic?site?by?pathogenicity? analysis?according?to?the?guidelines?of?American?College?of?Medical?Genetics?and?Genomics?(ACMG).?The?younger?brother,?father, and aunt of?the?proband?all?had?the?same?heterozygous?mutation?as?the?proband.?The?younger?brother?of?the?proband?manifested?epilepsy.? His?father?and?aunt?also?manifested?PED.?Conclusion The SLC2A1?gene?mutation?and?genetic?characteristics?of?the?family?were? clarified,?and?the?newly?discovered?mutation?site?of?c.?940G>A?(p.?Gly314Ser)?enriched?the?SLC2A1 gene mutation spectrum.
    The oral-facial-digital type Ⅰsyndrome: a case report and literature review
    BAO Lisha, LI Jing, LIU Fang
    Journal of Clinical Pediatrics. 2020, 38(10):  769.  doi:10.3969/j.issn.1000-3606.2020.10.012
    Abstract ( 519 )   PDF (1729KB) ( 320 )  
    Related Articles | Metrics
    Objective? To?explore?the?clinical?and?genetic?variation?characteristics?of?the?oral-facial-digital?type?I syndrome. Method? The clinical data and gene test results of oral-facial-digital type I?syndrome?in?a?child?were?retrospectively?analyzed,?and? the?related?literature?was?reviewed.?Results? The?girl?was?admitted?to?the?hospital?2?days?after?birth?due?to?weak?suck?and?congenital? cleft?palate.?She?presented?a?distinctive?facial?appearance?such?as?frontal?bossing,?hypertelorism,?epicanthic?folds,?a?micro?chin,? low-set?ears,?cleft?palate,?multi-lobulated?tongue?(two?lobes),?tongue?hamartoma,?thick?alveolar?ridges,?facial?asymmetry?and?toe? deformity.?Genomic?sequencing?and?bioinformatics?analysis?showed?a?heterozygous?mutation,?c.312?+?2T>A?(thymine?>?adenine),? in intron 3 of OFD1 gene on the X chromosome. Conclusion? The?child?was?diagnosed?with?oral-facial-digital?syndrome,?and?the? OFD1?gene?mutation?spectrum?was?expanded.
    Diagnosis and treatment of biotinase deficiency with manifestations of wheezing and psychomotor retardation in a case
    XIE Lina, MAO Yingying, CHEN Qian, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  773.  doi:10.3969/j.issn.1000-3606.2020.10.013
    Abstract ( 486 )   PDF (1356KB) ( 433 )  
    Related Articles | Metrics
    Objective To?explore?the?clinical?characteristics,?diagnosis?and?treatment?of?biotinidase?deficiency?(BTDD).? Method? The?clinical?data?of?BTDD?caused?by?biotinidase?gene?mutation?in?a?child?was?analyzed?retrospectively,?and?the? literature?was?reviewed.?Results? A?13-month-old?boy?had?onset?at?8?months?after?birth.?He?presented?with?recurrent?wheezing,? gross?motor?development?regression,?refractory?metabolic?acidosis?combined?with?compensatory?respiratory?alkalosis.?Urine? organic?acid?analysis?showed?that?the?levels?of?lactic?acid,?ketone?bodies,?succinic?acid,?fumaric?acid,?2.3DH2MB,?3meglutarconate,?and?malic?acid?were?increased.?The?activity?of?biotinidase?decreased?significantly.?The?whole-exome?gene?test? revealed?that?the?child?had?a?homozygous?variant?c.1493dupT?in?the?BTD?gene,?which?came?from?both?his?parents?with?normal? phenotype,?and?it?was?a?pathogenic?variant.?He?was?confirmed?with?the?diagnosis?of?BTDD.?The?wheezing?symptoms?in?the?child? were?relieved?within?a?few?hours?after?biotin?supplementation.?Conclusion? Children?with?suspected?BTDD?should?be?tested?by? hematuria?tandem?mass?spectrometry?as?soon?as?possible.?The?tests?for?biotinidase?activity?and?gene?should?be?improved.
    Cohen syndrome caused by compound heterozygous variation in VPS13B gene: a case report and literature review
    CAO Yuhong, ZHANG Guangyun, CAO Kaifang, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  777.  doi:10.3969/j.issn.1000-3606.2020.10.014
    Abstract ( 871 )   PDF (1485KB) ( 474 )  
    Related Articles | Metrics
    Objective? To?explore?the?clinical?and?genetic?variation?characteristics?of?Cohen?syndrome.?Methods The clinical?data?and?molecular?genetic?test?results?of?Cohen?syndrome?in?a?child?were?retrospectively?analyzed,?and?the?related? literature?was?reviewed.?Results? A?1-year-?and?3-month-old?boy?visited?for?psychomotor?retardation.?He?presented?with?thick? hair,?hypertelorism,?down-slanting?palpebral?fissures,?short?philtrum,?a?short?upper?lip,?hyperlinear?and?single?transverse?palmar? creases,?joint?hypermobility,?hypotonia?and?neutropenia.?Brain?magnetic?resonance?imaging?showed?bilateral?ventricles?enlarged? and?extracerebral?spaces?widened.?Gene?detection?showed?compound?heterozygous?variants?of?c.3863delC?(p.T1288fs)?and? c.5082delT?(p.S1694fs)?in?VPS13B?gene,?which?came?from?parents?with?normal?phenotype.?The?variation?was?predicted?to?be? pathogenic?by?related?software,?and?they?have?not?been?reported.?Conclusions? The?child?was?diagnosed?with?Cohen?syndrome,? and the VPS13B?gene?variant?spectrum?in?Cohen?syndrome?patients?was?expanded.
    Height growth retardation in a child with acute myeloid leukemia caused by tyrosine kinase inhibitor: a case report and literature review
    ZHENG Fangyuan, ZHANG Leping
    Journal of Clinical Pediatrics. 2020, 38(10):  781.  doi:10.3969/j.issn.1000-3606.2020.10.015
    Abstract ( 440 )   PDF (1654KB) ( 152 )  
    Related Articles | Metrics
     Objective To?explore?the?effect?of?tyrosine?kinase?inhibitor?on?height?growth?in?children?with?acute?myeloid? leukemia. Method? The?clinical?data?of?a?child?with?height?growth?retardation?caused?by?tyrosine?kinase?inhibitor?were? retrospectively?analyzed,?and?the?relevant?review?was?reviewed.?Results? The?female?child?had?a?fraternal?twin?sister?with?similar? body?weight?at?birth.?At?the?age?of?19?months,?the?child?was?diagnosed?of?acute?myeloid?leukemia?by?clinical,?blood?routine,?bone? marrow?morphology,?immunology,?molecular, ?and?genetic?genetics.?Genetic?detection?showed?CBFβ-MYH11?fusion?gene?(531.8%)? and?positive?c-kitD419-L42 1delins WN,?and?the?child?received?routine?chemotherapy.?At?that?time,?the?height?of?the?child?and?her? sibling?were?both?at?the?P90?of?the?growth?curve?of?the?same?age?and?sex?in?China.?The?child’s?bone?marrow?was?completely?relieved? after?induction?chemotherapy,?but?the?CBF -MyH11?gene?did?not?turn?negative.?After?the?consolidation?chemotherapy,?the?treatment? with?imatinib?was?added?and?the?gene?turned?negative,?but?the?child?showed?slower?growth?in?height?(from?P90 to P75).?After?the? cessation?of?imatinib,?the?growth?rate?of?height?recovered.?However,?due?to?intermittent?positive?of?CBFβ-MYH11?gene,?imatinib? was?added,?and?the?height?growth?was?reduced.?With?dasatinib?to?replace?imatinib,?the?increase?in?height?was?still?slowed?down.?At?9? years?and?10?months?of?the?follow-up,?the?height?of?the?child?was?134?cm?at?P10~P25,?while?her?sibling?sister?was?146?cm,?still?at?P90. Conclusion? Tyrosine?kinase?inhibitors?can?cause?height?growth?retardation?in?acute?myeloid?leukemia?child.
    Glucose-6-phosphate isomerase deficiency caused by GPI gene mutation: a case report and literature review
    HUANG Peng, TANG Li, WANG Aiping, et al
    Journal of Clinical Pediatrics. 2020, 38(10):  785.  doi:10.3969/j.issn.1000-3606.2020.10.016
    Abstract ( 674 )   PDF (1470KB) ( 216 )  
    Related Articles | Metrics
    Objective To explore the clinical characteristics and pathogenic genes of glucose-6-phosphate isomerase (GPI)?deficiency.?Method? The?clinical?data?of?GPI?deficiency?in?a?child?was?retrospectively?analyzed,?and?the?related?literature? was?reviewed.?Results? A?4-year-?and?3-month-old?boy?suffered?from?repeated?anemia?and?jaundice?since?birth,?accompanied? by?hepatosplenomegaly,?knee?joint?pain?and?gross?motor?development?retardation.?No?abnormality?was?found?in?G6PD?enzyme,? pyruvate?kinase,?hemoglobin?electrophoresis,?direct?Coombs?test,?erythrocyte?fragility?and?bone?marrow?cytological?examination.? Knee?joint?MRI?showed?a?small?amount?of?fluid?and?synovitis?in?both?knee?joints.?Whole?exome?sequencing?showed?that?there?was? a?homozygous?missense?mutation,?c.553T>A?(F185I),?in?exon?6?of?the?GPI?gene.?Sanger?sequencing?verified?that?they?were?from? their?parents?and?it?was?a?new?mutation?not?reported?before.?The?mutation?was?pathogenic.?Conclusion? GPI?deficiency?is?a?rare? autosomal?recessive?genetic?disease,?and?early?genetic?testing?can?assist?in?the?diagnosis.
    Status and progress of research in biomarkers for the diagnosis of Kawasaki disease
    WANG Liang, SI Ping
    Journal of Clinical Pediatrics. 2020, 38(10):  789.  doi:10.3969/j.issn.1000-3606.2020.10.017
    Abstract ( 404 )   PDF (1201KB) ( 231 )  
    Related Articles | Metrics
    Kawasaki?disease?(KD)?is?an?acute?febrile?and?rash?disease?with?systemic?vasculitis?as?the?main?pathological? change.?The?coronary?artery?lesion?(CAL)?is?the?most?serious?complication?of?KD.?KD?has?the?characteristics?of?seasonality,? regionality,?self-limitation?and?high?incidence?in?infants?and?young?children.?Early?administration?of?intravenous?immunoglobulin? (IVIG)?can?prevent?the?occurrence?of?CAL?in?most?children.?However,?some?children?are?still?unresponsive?to?IVIG,?and?the? incidence?of?CAL?is?higher.?Therefore,?early?diagnosis?of?KD?is?of?great?significance?for?reducing?CAL?and?improving?the?life? quality?of?KD?children.?This?paper?reviews?the?current?status?and?progress?of?related?research.
    Application and prospect of gene therapy for rare diseases
    GUI Yiting, LI Qiang, GUI Yonghao
    Journal of Clinical Pediatrics. 2020, 38(10):  794.  doi:10.3969/j.issn.1000-3606.2020.10.018
    Abstract ( 506 )   PDF (1199KB) ( 478 )  
    Related Articles | Metrics
    The?incidence?of?rare?diseases?is?extremely?low,?but?most?of?them?are?serious?and?tend?to?occur?in?childhood.? Mostly?they?are?caused?by?genetic?mutations.?Due?to?the?small?number?of?patients?and?low?market?demand,?the?research?and? development?cost?of?rare?disease?drugs?is?very?high,?and?only?less?than?1%?of?rare?diseases?have?drugs?available?for?treatment.? With?the?advancement?of?genetic?diagnosis?technology,?gene?therapy?by?virtue?of?its?"one-time?complete?cure"?feature?has? brought?hope?to?patients?with?hereditary?rare?diseases.?This?article?reviews?the?current?status?of?gene?therapy?for?rare?diseases,?and? discusses?the?application?and?development?of?traditional?gene?delivery?technologies?and?gene?editing?technologies?represented?by? CRISPR-Cas9?in?rare?diseases.